OPVERSE Trademark

Trademark Overview


On Monday, October 20, 2025, a trademark application was filed for OPVERSE with the United States Patent and Trademark Office. The USPTO has given the OPVERSE trademark a serial number of 99452213. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 12, 2026. This trademark is owned by NATIONAL TAIWAN UNIVERSITY. The OPVERSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Provision of biological research services; Provision of bacteriological research services; Scientific Research in the nature of conducting clinical trials for pharmaceutical drugs and reagents for others; Scientific Research in the nature of conducting clinical trial services for others; Research and analytical services relating to pharmaceutical drugs and reagents; Provision of medical research services; Research and development services in the field of allogeneic stem cell-based pharmaceuticals; Research and development services in the field of cell therapy and Contract Development and Manufacturing Organization (CDMO) solutions
opverse

General Information


Serial Number99452213
Word MarkOPVERSE
Filing DateMonday, October 20, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 12, 2026

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProvision of biological research services; Provision of bacteriological research services; Scientific Research in the nature of conducting clinical trials for pharmaceutical drugs and reagents for others; Scientific Research in the nature of conducting clinical trial services for others; Research and analytical services relating to pharmaceutical drugs and reagents; Provision of medical research services; Research and development services in the field of allogeneic stem cell-based pharmaceuticals; Research and development services in the field of cell therapy and Contract Development and Manufacturing Organization (CDMO) solutions
Description of MarkThe mark consists of the stylized wording "OPVERSE".

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 20, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNATIONAL TAIWAN UNIVERSITY
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTaipei 10617
TW

Party NameNATIONAL TAIWAN UNIVERSITY
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTaipei 10617
TW

Trademark Events


Event DateEvent Description
Monday, October 20, 2025NEW APPLICATION ENTERED
Monday, October 20, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, March 4, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 6, 2026ASSIGNED TO EXAMINER
Friday, March 6, 2026NON-FINAL ACTION WRITTEN
Friday, March 6, 2026NON-FINAL ACTION E-MAILED
Friday, March 6, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 9, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2026PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED